NIH | National Cancer Institute | NCI Wiki  

WIKI MAINTENANCE NOTICE

Please be advised that NCI Wiki will be will be undergoing maintenance on Monday, June 24th between 1000 ET and 1100 ET.
Wiki will remain available, but users may experience screen refreshes or HTTP 502 errors during the maintenance period. If you encounter these errors, wait 1-2 minutes, then refresh your page.

If you have any questions or concerns, please contact the CBIIT Atlassian Management Team.

Versions Compared

Old Version 13

changes.mady.by.user Morrissey, Laurie (NIH/NCI) [C]

Saved on

compared with

New Version Current

changes.mady.by.user Morrissey, Laurie (NIH/NCI) [C]

Saved on

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.
Excerpt

Dr. Javed KhanImage Modified

SYNOPSIS:

Dr. Javed KahnKhan, Deputy Chief of NCI's Genetics Branch and Senior Investigator and Head of the Oncogenomics Section, will discuss the following:

1. Success and Challenges of Treating Pediatric Cancers.

2. Biomarkers, Drivers, and Therapeutic Targets

3. Using first Generation Genomics to identify biologically relevant therapeutic targets

4. Next generation genomics of pediatric cancers

5. Tumor heterogeneity

6. Next Generation Therapeutics: Personalized Therapies and Immunogenomics

7. Enabling Precision Therapy Trials in CCR

Session details...

BIO:

Dr. Javed Khan obtained his bachelor's degree in 1984 and his master's degrees in 1989 in immunology and parasitology at England's University of Cambridge. He subsequently obtained his M.D. there and the postgraduate degree of MRCP (Membership of the Royal College of Physicians), equivalent to board certification in the United States. After clinical training in internal medicine and pediatrics as well as other specialties, he received a Leukemia Research Fellowship. In May 2001, Dr. Khan joined the Pediatric Branch, NCI, as a tenure track investigator. Dr. Khan  Khan and colleagues have published a new model for diagnosis of cancer using artificial neural networks (ANN), a form of artificial intelligence, and microarray technology. In April 2001, Dr. Khan  Khan was recognized by the American Association for Cancer Research for his work in tumor profiling by receiving a Scholar in Training Award. Recently Dr. Khan  Khan has led an international collaboration to perform comprehensive analysis of pediatric cancer genomes using next generation sequencing strategies.

...

Topic: Cancer Genomics to Identify Novel Biomarkers and Drivers and to Enable Precision Therapeutics

Speaker: Javed KahnKhan, M.D.

Date: Wednesday, June 24, 2015

...

You are invited to listen to Dr. KahnKhan's presentation in Room 2W908 in the NCI Shady Grove Building on Medical Center Drive or via WebEx.WebEx Meeting Link: https://cbiit.webex.com/cbiit/onstage/g.php?MTID=ecdbe84f2248df231c360e2d9ccc5f5ac

Password: $Peakerseries15

Meeting ID: 732 251 409

Dial-In for Audio Only: 1-855-244-8681

Presentation: A screen cast of the presentation will be available for viewing after the event on our Speaker Series Videos page and on the NCI CBIIT Speaker Series YouTube Playlist

Multiexcerpt include
MultiExcerptNameExitDisclaimer
nopaneltrue
MultiExcerptNameExitDisclaimer
PageWithExcerptwikicontent:Exit Disclaimer to Include

Widget Connector
urlhttps://www.youtube.com/watch?v=pM8SnmaNRMA&index=24&list=PLYKy4VbxNln5j89ESpYBVUkeFDbmQwxYG

About the NCI CBIIT Speaker Series:

...